Literature DB >> 14762100

Cooperation between aspirin-triggered lipoxin and nitric oxide (NO) mediates antiadhesive properties of 2-(Acetyloxy)benzoic acid 3-(nitrooxymethyl)phenyl ester (NCX-4016) (NO-aspirin) on neutrophil-endothelial cell adherence.

Stefano Fiorucci1, Eleonora Distrutti, Andrea Mencarelli, Giovanni Rizzo, Anna Rita Di Lorenzo, Monia Baldoni, Piero Del Soldato, Antonio Morelli, John L Wallace.   

Abstract

2-(Acetyloxy)benzoic acid 3-(nitrooxymethyl)phenyl ester (NCX-4016) is a nitric oxide (NO)-releasing derivative of aspirin that inhibits cyclooxygenase (COX) activity and releases NO. Acetylation of COX-2 by aspirin activates a transcellular biosynthetic pathway that switches eicosanoid biosynthesis from prostaglandin E(2) to 15-epi-lipoxin (LX)A(4) or aspirin-triggered lipoxin (ATL). Here, we demonstrate that exposure of neutrophil (PMN)/human umbilical vein endothelial cell (HUVEC) cocultures to aspirin and NCX-4016 triggers ATL formation and inhibits cell-to-cell adhesion induced by endotoxin (LPS) and interleukin (IL)-1beta by 70 to 90%. However, although selective and nonselective COX-2 inhibitors (celecoxib, rofecoxib, and naproxen) or N-t-butoxycarbonylmethionine-leucine-phenylalanine (Boc-1), an LXA(4) receptor antagonist, reduced the antiadhesive properties of aspirin by approximately 70%, antiadhesive effects of NCX-4016 were only marginally affected ( approximately 30%) by COX inhibitors and Boc-1, implying that COX-independent mechanisms mediate the antiadhesive properties of NCX-4016. Indeed, NCX-4016 causes a long-lasting (up to 12 h) release of NO and cGMP accumulation in HUVEC. Scavenging NO with 10 mM hemoglobin, in the presence of celecoxib, reduced the antiadhesive properties of NCX-4016 by approximately 80%. Confirming a role for NO, the NO donor diethylenetriamine-NO also inhibited PMN/HUVEC adhesion by approximately 80%. NCX-4016, but not aspirin, decreased DNA binding of nuclear factor-kappaB (NF-kappaB) on gel shift analysis and HUVEC's overexpression of CD54 and CD62E induced by LPS/IL-1beta. Reduction of binding of the two NF-kappaB subunits p50-p50 and p50-p65 was reversed by dithiothreitol, implying S-nitrosylation as mechanism of inhibition. In summary, our results support that ATL and NO are formed at the PMN/HUVEC interface after exposure to NCX-4016 and mediate the antiadhesive properties of this compound.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14762100     DOI: 10.1124/jpet.103.063651

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

Review 1.  Resolution of inflammation in periodontitis.

Authors:  Alpdogan Kantarci; Thomas E Van Dyke
Journal:  J Periodontol       Date:  2005-11       Impact factor: 6.993

2.  Quinone-induced activation of Keap1/Nrf2 signaling by aspirin prodrugs masquerading as nitric oxide.

Authors:  Tareisha Dunlap; Sujeewa C Piyankarage; Gihani T Wijewickrama; Samer Abdul-Hay; Michael Vanni; Vladislav Litosh; Jia Luo; Gregory R J Thatcher
Journal:  Chem Res Toxicol       Date:  2012-10-18       Impact factor: 3.739

Review 3.  A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution.

Authors:  Charles N Serhan
Journal:  Histochem Cell Biol       Date:  2004-08-21       Impact factor: 4.304

4.  15-epi-lipoxin A4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation.

Authors:  Mark J Paul-Clark; Thong Van Cao; Niloufar Moradi-Bidhendi; Dianne Cooper; Derek W Gilroy
Journal:  J Exp Med       Date:  2004-07-05       Impact factor: 14.307

Review 5.  Food-derived bioactive peptides on inflammation and oxidative stress.

Authors:  Subhadeep Chakrabarti; Forough Jahandideh; Jianping Wu
Journal:  Biomed Res Int       Date:  2014-01-02       Impact factor: 3.411

6.  The Contribution of Formyl Peptide Receptor Dysfunction to the Course of Neuroinflammation: A Potential Role in the Brain Pathology.

Authors:  Ewa Trojan; Natalia Bryniarska; Monika Leśkiewicz; Magdalena Regulska; Katarzyna Chamera; Magdalena Szuster-Głuszczak; Marcello Leopoldo; Enza Lacivita; Agnieszka Basta-Kaim
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

Review 7.  Perspectives on the Potential Benefits of Antihypertensive Peptides towards Metabolic Syndrome.

Authors:  Forough Jahandideh; Jianping Wu
Journal:  Int J Mol Sci       Date:  2020-03-22       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.